Limula
PrivateLast Round
Seed
May 21, 2024
Total Funding Raised
$14.77M
Momentum Score
50 /100
Company Overview
Limula is a biotechnology company that offers an automated gene therapy platform designed to enhance the accessibility and scalability of personalized cell and gene therapies for patients in need.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Precision Medicine, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Limula Comps
Public and private peers based on sector, stage, and business model.
Limula Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 21, 2024 | ||||
| Grant | Oct 5, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Grant | Apr 28, 2023 | ||||
| Grant | Oct 11, 2022 | ||||
Grant | Jun 15, 2022 |
Key People
Founding team and executive leadership
Limula Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 19, 2026
Limula SA is developing an automated Cell and Gene Therapy manufacturing platform.
- Jun 18, 2025
Oliver Dick joins the Strategic Advisory Board.
Limula Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Limula's valuation, stock price, and market status.
